Wille Finance

Zürich, Switzerland
Private equity
Active
Total investments

20

Average round size

20M

Portfolio companies

18

Rounds per year

1.18

Lead investments

3

Follow on index

0.10

Areas of investment
BiotechnologyDrug DiscoverySoftwareInformation TechnologyArtificial IntelligenceHealth CareSaaSPeer to PeerMedical DevicePharmaceutical

Investor highlights

Stage focus
Series ASeries B
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 36 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
20
Lead investments
3
Rounds per year
1.18
Follow on index
0.10
Investments by industry
  • Health Care (6)
  • Software (6)
  • SaaS (5)
  • Information Technology (5)
  • Artificial Intelligence (4)
  • Show 39 more
Investments by region
  • Germany (6)
  • Austria (2)
  • France (7)
  • Iceland (1)
  • Switzerland (3)
  • Show 1 more
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
ImmunOs Therapeutics10 Dec 2019Biotechnology, Drug Discovery, Health Care, PharmaceuticalEarly Stage Venture16MSwitzerland, Zurich
Qummy01 Apr 2021Food and Beverage, Food Delivery, CookingSeedKrasnodar Krai, Krasnodar, Russia
StoryBox19 Jun 2024Software, SaaS, VideoEarly Stage Venture6MBayern, Munich, Germany
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.